Yifeng Total Liab vs Total Stockholder Equity Analysis

603939 Stock

24.54 0.05 0.20%

Yifeng Pharmacy financial indicator trend analysis is more than just analyzing Yifeng Pharmacy current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Yifeng Pharmacy is a good investment. Please check the relationship between Yifeng Pharmacy Total Liab and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yifeng Pharmacy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Liab vs Total Stockholder Equity

Total Liab vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Yifeng Pharmacy Total Liab account and Total Stockholder Equity. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Yifeng Pharmacy's Total Liab and Total Stockholder Equity is 0.98. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Yifeng Pharmacy, assuming nothing else is changed. The correlation between historical values of Yifeng Pharmacy's Total Liab and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Yifeng Pharmacy are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Liab i.e., Yifeng Pharmacy's Total Liab and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.98

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Yifeng Pharmacy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Yifeng Pharmacy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yifeng Pharmacy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 2 B, whereas Tax Provision is forecasted to decline to about 319.5 M.

	2022	2023	2024	2025 (projected)
Operating Income	2.0B	2.1B	2.3B	2.4B
Total Revenue	19.9B	22.6B	24.1B	25.3B

Operating Income Total Revenue

Yifeng Pharmacy fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Retained Earnings	Good Will	Net Tangible Assets	Short Term Investments	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Common Stock Shares Outstanding
Total Assets		0.24	1.0	0.99	0.38	1.0	0.85	0.99	0.99	1.0	0.66	1.0	0.86	0.97	0.97	1.0	0.89	0.82	0.72	0.99	0.55	0.99	0.93	0.21	0.97	0.79
Other Current Liab	0.24		0.22	0.29	0.14	0.18	0.57	0.35	0.24	0.28	0.54	0.21	0.51	0.35	0.32	0.18	0.48	0.3	-0.37	0.32	0.37	0.16	0.37	0.21	0.21	-0.24
Total Current Liabilities	1.0	0.22		0.98	0.38	1.0	0.85	0.98	0.99	0.99	0.63	1.0	0.85	0.95	0.97	1.0	0.88	0.81	0.72	0.99	0.52	0.99	0.93	0.18	0.97	0.81
Total Stockholder Equity	0.99	0.29	0.98		0.37	0.98	0.86	0.99	0.98	0.99	0.72	0.98	0.88	0.98	0.95	0.98	0.91	0.83	0.69	0.99	0.61	0.97	0.93	0.26	0.95	0.76
Other Liab	0.38	0.14	0.38	0.37		0.37	0.41	0.36	0.38	0.38	0.27	0.38	0.46	0.32	0.36	0.37	0.43	0.42	0.22	0.39	0.26	0.38	0.45	0.05	0.35	0.39
Accounts Payable	1.0	0.18	1.0	0.98	0.37		0.82	0.97	0.99	0.99	0.63	1.0	0.84	0.95	0.96	1.0	0.86	0.8	0.75	0.98	0.52	0.99	0.92	0.16	0.97	0.82
Cash	0.85	0.57	0.85	0.86	0.41	0.82		0.89	0.84	0.86	0.73	0.84	0.96	0.86	0.88	0.82	0.95	0.82	0.33	0.87	0.59	0.8	0.93	0.34	0.81	0.63
Other Assets	0.99	0.35	0.98	0.99	0.36	0.97	0.89		0.96	0.99	0.7	0.98	0.89	0.98	0.98	0.98	0.91	0.83	0.65	1.0	0.62	0.97	0.93	0.29	0.97	0.72
Net Receivables	0.99	0.24	0.99	0.98	0.38	0.99	0.84	0.96		0.98	0.71	0.98	0.87	0.94	0.92	0.99	0.89	0.81	0.68	0.97	0.57	0.97	0.93	0.18	0.93	0.8
Inventory	1.0	0.28	0.99	0.99	0.38	0.99	0.86	0.99	0.98		0.68	0.99	0.87	0.97	0.97	0.99	0.9	0.81	0.69	1.0	0.56	0.98	0.93	0.2	0.97	0.76
Other Current Assets	0.66	0.54	0.63	0.72	0.27	0.63	0.73	0.7	0.71	0.68		0.62	0.83	0.7	0.55	0.62	0.84	0.54	0.22	0.68	0.85	0.6	0.68	0.46	0.57	0.39
Total Liab	1.0	0.21	1.0	0.98	0.38	1.0	0.84	0.98	0.98	0.99	0.62		0.84	0.95	0.97	1.0	0.87	0.8	0.73	0.99	0.51	0.99	0.92	0.17	0.98	0.8
Intangible Assets	0.86	0.51	0.85	0.88	0.46	0.84	0.96	0.89	0.87	0.87	0.83	0.84		0.85	0.84	0.84	0.98	0.82	0.37	0.88	0.65	0.81	0.94	0.3	0.8	0.66
Common Stock	0.97	0.35	0.95	0.98	0.32	0.95	0.86	0.98	0.94	0.97	0.7	0.95	0.85		0.94	0.95	0.89	0.84	0.65	0.97	0.62	0.94	0.9	0.3	0.93	0.69
Property Plant Equipment	0.97	0.32	0.97	0.95	0.36	0.96	0.88	0.98	0.92	0.97	0.55	0.97	0.84	0.94		0.96	0.85	0.83	0.64	0.98	0.48	0.95	0.92	0.21	0.97	0.73
Retained Earnings	1.0	0.18	1.0	0.98	0.37	1.0	0.82	0.98	0.99	0.99	0.62	1.0	0.84	0.95	0.96		0.86	0.82	0.74	0.99	0.53	0.99	0.92	0.17	0.97	0.82
Good Will	0.89	0.48	0.88	0.91	0.43	0.86	0.95	0.91	0.89	0.9	0.84	0.87	0.98	0.89	0.85	0.86		0.77	0.41	0.9	0.64	0.84	0.94	0.32	0.84	0.69
Net Tangible Assets	0.82	0.3	0.81	0.83	0.42	0.8	0.82	0.83	0.81	0.81	0.54	0.8	0.82	0.84	0.83	0.82	0.77		0.51	0.83	0.54	0.79	0.89	0.13	0.74	0.74
Short Term Investments	0.72	-0.37	0.72	0.69	0.22	0.75	0.33	0.65	0.68	0.69	0.22	0.73	0.37	0.65	0.64	0.74	0.41	0.51		0.66	0.28	0.79	0.49	0.08	0.75	0.72
Deferred Long Term Liab	0.99	0.32	0.99	0.99	0.39	0.98	0.87	1.0	0.97	1.0	0.68	0.99	0.88	0.97	0.98	0.99	0.9	0.83	0.66		0.58	0.98	0.94	0.22	0.97	0.75
Long Term Investments	0.55	0.37	0.52	0.61	0.26	0.52	0.59	0.62	0.57	0.56	0.85	0.51	0.65	0.62	0.48	0.53	0.64	0.54	0.28	0.58		0.52	0.53	0.73	0.48	0.35
Total Current Assets	0.99	0.16	0.99	0.97	0.38	0.99	0.8	0.97	0.97	0.98	0.6	0.99	0.81	0.94	0.95	0.99	0.84	0.79	0.79	0.98	0.52		0.89	0.19	0.98	0.8
Non Current Assets Total	0.93	0.37	0.93	0.93	0.45	0.92	0.93	0.93	0.93	0.93	0.68	0.92	0.94	0.9	0.92	0.92	0.94	0.89	0.49	0.94	0.53	0.89		0.15	0.88	0.8
Non Currrent Assets Other	0.21	0.21	0.18	0.26	0.05	0.16	0.34	0.29	0.18	0.2	0.46	0.17	0.3	0.3	0.21	0.17	0.32	0.13	0.08	0.22	0.73	0.19	0.15		0.21	0.08
Non Current Liabilities Total	0.97	0.21	0.97	0.95	0.35	0.97	0.81	0.97	0.93	0.97	0.57	0.98	0.8	0.93	0.97	0.97	0.84	0.74	0.75	0.97	0.48	0.98	0.88	0.21		0.74
Common Stock Shares Outstanding	0.79	-0.24	0.81	0.76	0.39	0.82	0.63	0.72	0.8	0.76	0.39	0.8	0.66	0.69	0.73	0.82	0.69	0.74	0.72	0.75	0.35	0.8	0.8	0.08	0.74

Click cells to compare fundamentals

Yifeng Pharmacy Account Relationship Matchups

Yifeng Pharmacy fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	12.9B	17.1B	21.0B	24.1B	28.0B	29.4B
Other Current Liab	525.1M	672.4M	1.0B	22.6M	34.2M	32.5M
Total Current Liabilities	5.9B	6.7B	9.7B	11.3B	12.6B	13.2B
Total Stockholder Equity	5.5B	7.5B	8.6B	9.8B	10.7B	11.3B
Other Liab	54.1M	53.9M	52.5M	78.4M	90.2M	48.4M
Accounts Payable	3.8B	4.8B	6.8B	8.2B	9.5B	10.0B
Cash	3.4B	2.9B	4.1B	3.6B	3.6B	1.8B
Other Assets	239.8M	400.0M	517.8M	568.5M	653.7M	686.4M
Net Receivables	830.3M	1.1B	1.8B	2.1B	2.1B	2.2B
Inventory	2.2B	3.0B	3.6B	3.8B	4.5B	4.8B
Other Current Assets	341.7M	356.7M	466.0M	384.1M	407.7M	309.5M
Total Liab	7.2B	9.2B	11.9B	13.7B	16.6B	17.4B
Intangible Assets	375.3M	396.5M	485.5M	474.5M	486.3M	290.0M
Common Stock	378.9M	531.5M	718.8M	721.7M	830.0M	871.5M
Property Plant Equipment	528.0M	3.6B	4.5B	4.9B	5.6B	5.9B
Retained Earnings	2.1B	2.8B	3.9B	4.8B	5.4B	5.6B
Good Will	3.3B	3.7B	4.2B	4.6B	4.8B	2.8B
Net Tangible Assets	1.1B	1.7B	3.4B	3.9B	4.5B	2.3B
Short Term Investments	744.8M	152.2M	50.0M	1.6B	4.4B	4.6B
Deferred Long Term Liab	207.0M	267.4M	379.6M	430.7M	495.3M	520.1M
Total Current Assets	7.7B	7.9B	10.6B	12.1B	15.9B	16.6B
Non Current Assets Total	4.9B	9.1B	10.5B	12.0B	12.1B	7.2B
Non Currrent Assets Other	58.4M	28.4M	7.2M	30.3M	15.2M	22.6M
Non Current Liabilities Total	2.0B	2.4B	2.3B	2.4B	4.0B	4.2B
Common Stock Shares Outstanding	691.0M	718.8M	721.7M	1.2B	1.2B	906.4M
Net Invested Capital	7.8B	7.8B	8.8B	9.9B	12.4B	8.2B
Net Working Capital	2.9B	1.2B	918.9M	859.4M	3.3B	1.9B
Long Term Debt	2.0B	365.6M	228.7M	133.6M	1.6B	1.7B
Capital Stock	531.5M	718.8M	721.7M	1.0B	1.2B	778.0M
Property Plant And Equipment Net	812.6M	4.5B	4.9B	5.7B	5.7B	4.0B
Property Plant And Equipment Gross	1.2B	5.0B	4.9B	6.5B	5.7B	4.4B

Currently Active Assets on Macroaxis

SLDP	Solid Power
RIO	Rio Tinto ADR
SQM	Sociedad Quimica y
IHS	IHS Holding
BHP	BHP Group Limited

Other Information on Investing in Yifeng Stock

Balance Sheet is a snapshot of the financial position of Yifeng Pharmacy at a specified time, usually calculated after every quarter, six months, or one year. Yifeng Pharmacy Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Yifeng Pharmacy and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Yifeng currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Yifeng Total Liab vs Total Stockholder Equity Analysis

Total Liab vs Total Stockholder Equity

Total Liab vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Total Liab

Total Stockholder Equity

Yifeng Pharmacy fundamental ratios Correlations

Yifeng Pharmacy Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Yifeng Pharmacy fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Yifeng Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Assets
Inventory	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities

Short Term Investments	- 0.37	Other Current Liab
Common Stock Shares Outstanding	- 0.24	Other Current Liab